The first publication of the COMET research group is a fact. Digitalis Rx contributes to the international database.
Zuyderland MC has collaborated with Digitalis Rx on the development of a new RuleSet: CR COVID-19. These Rules can be used as part of the medication monitoring for the therapy policy at COVID-19.
Erasmus MC has started an investigation in collaboration with Digitalis Rx into the influence of medication on the clinical course of COVID-19. Data from patients in European hospitals are analyzed using Clinical Rules. Calling all hospitals: participate in this study!
Using a clinical decision support system medication reviews are performed in a standardised way which leads to comparable results between patients. In addition it eliminates the time factor to perform medication reviews as the major problems related to medication, laboratory values, indications and/or established patient characteristics will be directly available.
Polypharmacy is one of the main risk factors for adverse drug events, drug–drug interactions and undertreatment.